U.S. Asthma Therapies Markets
U.S. Asthma Therapies Markets
RELEASE DATE
14-Mar-2003
14-Mar-2003
REGION
North America
North America
Research Code: A342-01-00-00-00
SKU: HC00862-NA-MR_04592
$2,450.00
In stock
SKU
HC00862-NA-MR_04592
Description
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories, bronchodilator/corticosteroid combinations, and other emerging therapies. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Disease Definition
- Risk Factors
- Disease Classification
- Treatment
- Drug Delivery Methods
- Societal Economic Burden
- Challenges and Strategies
- Drivers
- Restraints
Market Dynamics
- Demand Analysis
- Market and Technology Trends
- Total Market Revenue Forecast
- Market Share Analysis
Frost & Sullivan Market Engineering Awards
- Market Leadership Award
- Strategic Alliance Leadership Award
- Brand Awareness Development Award
- Business Development Strategy Award
- Technology Innovation Award
Overview
Competitive Analysis
Short-Acting Beta2 Agonist Market
- Introduction
- Market Engineering Analysis
- Revenue Forecast
Long-Acting Beta2 Agonist Market
- Competitive Structure
- Market Share Analysis
Anticholinergics Market
- Introduction
- Market Engineering Analysis
- Revenue Forecast
- Pricing Trends
- Competitive Structure
- Market Share Analysis
- Product Analysis-Existing
- Product Analysis-Emerging
Methylxanthines Market
- Introduction
- Market Engineering Analysis
- Revenue Forecast
- Pricing Trends
- Competitive Structure
- Market Share Analysis
- Product Analysis-Existing
- Product Analysis-Emerging
Overview
Competitive Analysis
Inhaled Corticosteroid Market
Mediator-Release Inhibitor Market
Anti-Leukotriene Market
Other Emerging Anti-Inflammatory Therapies Market
Overview
Competitive Analysis
Popular Topics
This report provides revenue forecasts, market shares, projected prevalence, diagnosed and treated populations, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely bronchodilators, anti-inflammatories, bronchodilator/corticosteroid combinations, and other emerging therapies. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A342-01-00-00-00 |
Is Prebook | No |